Endologix Announces the Presentation of Favorable Powerlink System Clinical Data at 2007 VEITH Symposium

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX) today reported that favorable Powerlink® System clinical data was featured in two presentations on Saturday, November 17 at the 34th Annual VEITH Symposium in New York City. The presentations by Professor Dieter Raithel, M.D., Southern Clinic in Nuremburg, Germany, and Jeffrey Carpenter, M.D., University of Pennsylvania School of Medicine, are available on the Endologix Web site at http://www.endologix.com/health_clinical_presentations.php.

In his presentation “Why is the Endologix Powerlink Endograft with Fixation on the Aortic Bifurcation Best for Most AAAs?,” Professor Raithel reported that the Powerlink’s unique design characteristics make it superior in treating patients with aneurysm anatomy deemed unsuitable for other stent grafts. His conclusion was based on his experience with 1,492 stent graft procedures, including 492 Powerlink System cases over an 8½ year period. He stated that the Powerlink System is a critical component of his armamentarium that allows him to treat more than 90% of all eligible AAA patients with a stent graft.

Full story: Business Wire